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ABSTRACT: 38 
 39 
Reaction of methyl (E)-4-(benzylideneamino)benzoate C6H5CH]N(C6H4-4-CO2Me) with Pd(OAc)2 40 
produced the dinuclear acetato bridge ortho-cyclopalladated compound [Pd{C6H4CH]N(C6H4-4-41 
CO2Me)-kCortho,kN}]2(m-OAc)2 (1). Compounds [Pd{C6H4CH]N(C6H4-4-CO2Me)-42 
Cortho,kN}]2(m-Cl)2 (2) and [Pd{C6H4CH]N(C6H4-4-CO2Me)-kCortho,kN}(py)(X)] [3 (X ¼ OAc); 43 
4 (X ¼ Cl)] were also prepared and isolated in good yields by substitution reactions. 1H and 13C{1H} 44 
NMR in CDCl3 solution of compounds 3 and 4 revealed that they consisted of a mixture of trans- and 45 
cis-N,N isomers. Addition of pyridine-d5 to solutions of 1 and 2 in CDCl3 in a molar ratio pyridine-d5/1 46 
or 2 z 50e55 gave solutions A and B, respectively, which contained compounds 5 and 6 analogous to 3 47 
and 4, but with pyridine-d5 rather than pyridine in their structural formula. In these solutions, the trans- 48 
and cis-N,N geometrical isomers of compounds 5 and 6 were interconverting between them in a 49 
dynamic equilibrium. In addition, an exchange between free and coordinated pyridine-d5 was also 50 
taking place in solutions A and B. The NMR data for solution A showed that the dynamic equilibrium 51 
between the cis- and trans-N,N isomers of compound 5 was shifted to the trans-N,N isomer. However, 52 
the NMR data for solution B suggested that in this solution the equilibrium between the cis- and trans-53 
N,N isomers of compound 6 was shifted to the cis-N,N isomer. Interconversion between the trans- and 54 
cis-N,N isomers of compounds 5 and 6 in solutions A and B plausibly proceeded through the 55 
intermediate ionic complexes [Pd{C6H4CH]N(C6H4-4-CO2Me)-kCortho,kN}(py-d5)2]X [7 (X ¼ 56 
OAc), 8 (X ¼ Cl)]. Ionic complexes 7 and 8 were not observed in CDCl3 solution but were the major 57 
species in D2O solutions containing compounds 1 and 2 and pyridined5 in a molar ratio pyridine-d5/1 or 58 
2 z 50e55. The crystal structure of the adduct 1$2(CH3COOH) and that of compound 2 were determined 59 
by single crystal X-ray diffraction. A theoretical study on the difference in free Gibbs energy in CHCl3 60 
solution between the cis- and trans-N,N isomers of compounds 3 and 4 is also included in this work 61 
 62 
 63 
64 
1. INTRODUCITON 65 
 66 
In recent years, it has been shown that some N-donor cyclometallated palladium(II) compounds present 67 
anticancer activity, both in vitro and in vivo in mouse models [1e4]. The anticancer activity of these 68 
compounds can be modulated by modifying the substituents at the N-donor cyclometallated ligand or by 69 
changing through substitution reactions the co-ligands of the palladium(II) center [5,6]. Substitution 70 
reactions at palladium(II), in which the entering ligand is a DNA nitrogen base or a thiol function of an 71 
enzyme, such as Cathepsin B, or oxidation by palladium(II) of mitochondrial membrane protein thiol 72 
functions to disulphide groups, seem to be the starting reactions that could explain the cytotoxicity of 73 
this type of compounds towards cancer cells [4,7,8]. In addition, cyclopalladated compounds present 74 
application as precatalysts for carbon-carbon and carbon-heteroatom coupling reactions [9,10] and as 75 
Lewis acid catalysts for some organic reactions [9,11], between many other applications [12]. 76 
Furthermore, in recent years the cyclopalladation reaction has been successfully introduced in catalytic 77 
cycles that transform CeH bonds in CeC and C-heteroatom bonds [13e15]. Therefore, the study of the 78 
synthesis, reactivity and properties of cyclopalladated compounds is a subject of interest [12]. 79 
In this work, we deal with i) the synthesis and characterization of the dinuclear ortho-cyclopalladated 80 
compounds [Pd{C6H4CH] N(C6H4-4-CO2Me)-kCortho,kN}]2(m-X)2, compounds 1 (X ¼ OAc) and 2 81 
(X ¼ Cl), derived from methyl (E)-4-(benzylideneamino)benzoate C6H5CH]N(C6H4-4-CO2Me), ii) the 82 
synthesis and characterization of their pyridine and pyridine-d5 mononuclear derivatives [Pd 83 
{C6H4CH]N(C6H4-4-CO2Me)-kCortho,kN}(L)(X)], compounds 3 (L ¼ pyridine, X ¼ OAc), 4 (L ¼ 84 
pyridine, X ¼ Cl), 5 (L ¼ pyridine-d5, X ¼ OAc) and 6 (L ¼ pyridine-d5, X ¼ Cl), iii) the study of the 85 
stereochemistry and behaviour in solution of compounds 3e6, and iv) a computational study related with 86 
the difference in free Gibbs energy in CHCl3 solution between the cis- and trans-N,N isomers of 87 
compounds 3 and 4. 88 
89 
2. RESULTS AND DISCUSSION 90 
 91 
Scheme 1 outlines the methods of preparation of the compounds under study and gives their numbering, 92 
and that of their hydrogen and carbon atoms for the discussion that follows. Complete assignment of the 93 
signals of the 1H and 13C{1H} NMR for methyl (E)-4-(benzylideneamino)benzoate C6H5CH]N(C6H4-94 
4- CO2Me), compound 1 and the trans- and cis-N,N isomers of compounds 3 and 4, was achieved by 95 
two-dimensional 1He1H and 1He13C NMR experiments. 96 
Methyl (E)-4-(benzylideneamino)benzoate was synthesized by a condensation reaction between 97 
equimolecular amounts of benzaldehyde and methyl 4-aminobenzoate. The acetato bridge 98 
cyclopalladated compound (1) was prepared by a cyclopalladation reaction between equimolecular 99 
amounts of Pd(OAc)2 and methyl (E)-4-(benzylideneamino)benzoate. A metathesis reaction between 100 
compound 1 and an excess of LiCl was carried out to produce the chlorido bridge cyclopalladated 101 
complex (2). Details on the preparation of these compounds are given in Scheme 1 and in the 102 
experimental part. 103 
Methyl (E)-4-(benzylideneamino)benzoate was a pale yellow solid soluble in CDCl3, and in solution in 104 
this solvent afforded a single set of signals both in the 1H and in the 13C{1H} NMR. These results 105 
suggested that methyl (E)-4-(benzylideneamino)benzoate consisted of only the E-stereoisomer in 106 
relation to the imine function [16]. The methinic proton and the methinic carbon atomof methyl (E)-4-107 
(benzylideneamino)benzoate appeared at 8.44 and 161.7 ppm, respectively, and the C]N and C]O 108 
stretchings of the imine and ester functions produced intense bands at 1628 and  1717 cm 1, 109 
respectively. In addition, the ESI (þ) mass spectrum of methyl (E)-4-(benzylideneamino)benzoate gave 110 
an intense signal at 240.1 m/z, which corresponded to [MþH]þ. 111 
Compounds 1 and 2 were red and yellow solids, and were quite and slightly soluble in CDCl3, 112 
respectively. The C]N stretching of compounds 1 and 2 appeared at 1609 and  1605 cm 1, as an intense 113 
band shifted to lower wavenumbers in relation to the free imine, which was consistent with the 114 
coordination of the iminic nitrogen to the palladium(II) center [17]. The asymmetric and symmetric 115 
stretchings of the acetato carboxylic functions of 1 produced broad intense bands at 1574 and 1415 116 
 cm 1, indicating that the acetate ligands of 2 presented a bridging coordination mode [18]. The C]O 117 
stretching of the ester function for compounds 1 and 2 appeared at  1717 and 1719 cm 1, respectively. 118 
In addition, the LDI-TOF (þ) mass spectra of compounds 1 and 2 produced intense peaks for the cations 119 
 [M X]þ, where X was acetate for 1 and chloride for 2, in agreement with their dinuclear structure with 120 
acetato and chloride bridge ligands [19]. 121 
The main features of the 1H NMR of compound 1 in CDCl3 solution were i) the high-field shift of the 122 
methinic proton in relation to the free imine by 0.72 ppm, ii) the high-field shift of the H2 proton (6.58 123 
ppm) in relation to the free ligand (7.53e7.47 ppm), and iii) the presence of only one singlet produced by 124 
the methyl protons of the acetato ligands and by the protons of the methoxycarbonyl functions, which 125 
appeared at 1.86 and 3.95 ppm, respectively. Overall the precedent characterization data for compound 1 126 
were consistent with a kCortho,kN bidentate chelate coordination mode for its imine ligands and with 127 
this compound adopting a trans-folded dinuclear structure with acetato ligands bridging the 128 
palladium(II) centers [19e22].  129 
The 13C{1H} NMR in CDCl3 of compound 1 produced a single set of signals, which presented as 130 
principal features i) the low-field shift of the methinic and the metallated carbon atoms in relation to the 131 
free imine by 11.8 and 3.6 ppm, respectively, and ii) the single set of signals afforded by the carbon 132 
atoms of the acetato ligands, which appeared at 180.6 and 24.2 ppm, and by the carbon atoms of the 133 
methoxycarbonyl functions, which resonated at 166.4 and 52.3 ppm. These data were consistent with the 134 
kCortho,kN coordination mode of the imine ligands in compound 1 and with its trans stereochemistry 135 
[19]. 136 
The 1H NMR of compound 2 in CDCl3 at 298 K produced one set of signals, most of them broad, 137 
except the methinic protons, which afforded a singlet at 8.01 ppm, 0.43 ppm high-field shifted in 138 
relation to the free imine, and the protons of the methoxycarbonyl functions, which produced a singlet at 139 
3.96 ppm. The broadening of the proton NMR signals of dinuclear cyclopalladated compounds with 140 
chlorido bridge ligands in CDCl3 has been ascribed to a dynamic equilibrium between their cis and trans 141 
isomers [23]. 142 
X-ray quality yellow crystals of the adduct 1$2(CH3CO2H) and of compound 2 were obtained by slow 143 
evaporation at room temperature of a solution in acetic acid of 1 and of a solution in chloroform of 144 
complex 2, respectively. Adduct 1$2(CH3CO2H) and compound 2 crystallized in the triclinic P-1 with 145 
Z ¼ 2 and in the orthorhombic Pccn with Z ¼ 4 space groups, respectively. Details on the X-ray 146 
crystallographic structure determinations are given in the Supplementary Material. 147 
Figs. 1 and 2 show ball and stick models for the XRD molecules of compounds 1 and 2, respectively, 148 
together with some distances and angles for them. In the crystal of 1$2(CH3CO2H), the two halves of 149 
the molecule of 1 were not equivalent and differed between them only in small differences in distances 150 
and angles. On the other hand, in the crystal of 2, both halves of the molecule of 2 were equivalent since 151 
the molecule was situated over a crystallographic center of inversion. 152 
Bond distances and angles around of the palladium(II) centers for the molecules of 1 and 2 were 153 
between the normal intervals [5,19,24e26]. The chelate bite angles at palladium(II) showed the largest 154 
   deviations from the ideal angle of 90 , being 80.0(2)  and    80.7(2)  for 1 and 81.6 (4)  for 2. The 155 
five-membered metallacycles were planar and maximum deviated atoms from the fivemembered planar 156 
metallacycles were N(1) [0.008(5) Å] and N(2)  [ 0.022(5) Å] for 1 and C(3) [0.054(13) Å] for 2. In1 157 
and 2, the PdeO and PdeCl bonds trans to the metallated carbon atoms were longer than the 158 
corresponding bonds trans to the iminic nitrogen atom [Pd(1)eO(1) ¼ 2.161(4) Å and Pd(2)eO(4) ¼ 159 
2.156(4) Å but Pd(1) eO(3) ¼ 2.041(4) Å and Pd(2)eO(2) ¼ 2.050(4) Å for 1, and Pd1eCl2i ¼ 2.464 (3) 160 
Å but Pd1eCl2 ¼ 2.337 (3) Å for 2]. These results were in agreement with the greater trans influence of 161 
the palladated carbon atom in relation to the iminic nitrogen atom[27]. 162 
The angle between the palladacycles in compound 1 was  30.8(2)  and the distance between palladium 163 
atoms was 2.9175(13) Å. This distance was too long for being considered a palladiumepalladium single 164 
bond [28]. In compound 2, the palladacycles and the chlorido bridging ligands defined a plane (plane 1). 165 
For compound 1, the angles between the phenyls bonded to the iminic nitrogen atoms and the 166 
metallacycles were 50.8(3) and  41.0(3) , and for compound 2, the angle between the phenyls bonded to 167 
 the iminic nitrogen atoms and plane 1 was 5.89(13) . For compounds 1 and 2, the methoxycarbonyl 168 
functions and the phenyl groups bonded to the methoxycarbonyl functions were coplanar. 169 
Compounds 3e8 were prepared by splitting reactions between the corresponding compound 1 or 2 and 170 
pyridine (compounds 3e4) or pyridine-d5 (compounds 5e8). Compounds 3 and 4 were isolated and fully 171 
characterized, whereas compounds 5e8 were studied by NMR in CDCl3 solution (compounds 5 and 6) 172 
or in D2O solution (compounds 7 and 8) in both cases in presence of free pyridine-d5. 173 
Compounds 3 and 4 were isolated, as yellow and pale-yellow solids in 82 and 97% yield, respectively. 174 
These compounds produced satisfactory elemental analyses, IR and MALDI-TOF-(þ) mass spectra. In 175 
the IR spectrum of compound 3, bands at 1720, 1604 and  1586 cm 1 were assigned to the C]O 176 
stretching of the ester function, the C]N stretching of the imine function and the C]O stretching of the 177 
carboxylate function of the terminal acetate ligand, respectively. The C]N stretching of the pyridine 178 
ligand of compound 3 was obscured by the strong band corresponding to the C]O stretching of the 179 
carboxylate function of the terminal acetate ligand. In the IR spectrum of compound 4, bands at 1715, 180 
1604 and  1586 cm 1 were assigned to the C]O stretching of the ester function, the C]N stretching of the 181 
imine function and the C]N stretching of the pyridine ligand, respectively. The MALDI-TOF (þ) for 182 
compound 3 and 4 produced an intense signal for the cation  [M X]þ, where X was acetate for 183 
compound 3 and chloride for compound 4. In addition, compound 4 produced also intense signals for 184 
     the cations [2M Cl]þ and [2M Cl py]þ.  185 
Interestingly, compounds 3 and 4 isolated from the solution resulting from the reaction in CH2Cl2 of 186 
compounds 1 and 2 with pyridine in a molar ratio pyridine/1 or 2z3 consisted of a mixture of trans- and 187 
cis-N,N isomers (Scheme 1). The relative integral of the signals of the ortho protons of the coordinated 188 
pyridine allowed to establish the ratio between the trans and cis isomers of compounds 3 and 4 in 189 
CDCl3, which were 1.0:0.8 for compound 3 and 1.0:0.6 for compound 4. The ratio between the 190 
geometrical isomers of 3 and 4 in CDCl3 solution was unaltered after maintaining the precedent 191 
solutions at room temperature for two days. Interestingly, the cis-N,N isomer of compounds 3 and 4 192 
produced somewhat broad signals for the ortho protons of the coordinated pyridine, suggesting that an 193 
exchange between the coordinated pyridine trans to the palladated carbon atom and an adventitious free 194 
L ligand (water or pyridine)was taking place in these solutions. The strong trans effect produced by the 195 
metallated carbon atom into the coordinated pyridine in the cis-N,N isomer of compounds 3 and 4 196 
should favour this exchange [29]. 197 
Addition of pyridine-d5 to a solution of compound 1 in CDCl3 (ca. 6mg of compound 1 in 1 cm3 of 198 
CDCl3) in a molar ratio pyridine-d5/ 1 z 50e55 gave solution A. Solution A contained as observable 199 
palladium(II) compound by 1H NMR at 400 MHz and at room temperature, compound 5, which was 200 
analogous to compound 3 but with a pyridine-d5 ligand rather than a pyridine ligand in its structural 201 
formula. Doublet signals at 7.83 and 6.63 ppm and a singlet at 3.89 ppm were assigned to methyl 4-202 
aminobenzoate (4-H2NC6H4CO2Me). The molar ratio between compound 5 and methyl 4-203 
aminobenzoate was ca. 20. Noteworthy, compound 5 in solution A consisted of only the trans-N,N 204 
geometrical isomer by 1H NMR at 400 MHz and at room temperature. Thus, a large excess of pyridine-205 
d5 promoted the cis / trans isomerization of compound 5. The precedent results indicated that the cis- 206 
and trans-N,N isomers of compound 5 (or 3) were the kinetic and thermodynamic control products, 207 
respectively, for the reaction 1 þ 2 py-d5 (or 2 py) / 5 (or 3) (reaction a). For reaction a, the cis-N,N 208 
isomer should be the kinetic control product of the reaction due to the strong trans effect produced by 209 
the metallated carbon atoms into the acetato O-donor atoms trans to them in the initial compound 1 [29]. 210 
The signals of the aromatic protons of compound 6 in solution B at 500 MHz and at 298 K were broad 211 
but only one palladium(II) species was observed. Solution B was analogous to solution A but contained 212 
ca. 6 mg of compound 2 rather than 6mg of compound 1. In the 1H NMR of solution B at 500 MHz and 213 
at 298 K, the H10 and H9 protons of compound 6 produced broad signals at 7.97 and 7.12 ppm. These 214 
chemical shifts were between the chemical shifts of the H10 and H9 protons of the cis-N,N (7.76 and 215 
7.00 ppm) and the trans-N,N (8.09 and 7.51 ppm) isomers of compound 4. These results indicated that 216 
the cis- and trans-isomers of compound 6 were in a fast dynamic equilibrium between them in solution 217 
B. The lack of a signal of an aromatic proton in the interval between 7.00 and 6.00 ppm and the fact that 218 
the chemical shift of the H9 protons (7.12 ppm) was closer to the chemical shift of the H9 protons of the 219 
cis-N,N isomer (7.00 ppm) than that for the H9 protons of the trans-N,N isomer (7.51 ppm) suggested 220 
that the cis-N,N isomer of compound 6 was the major species in solution B. It should be noted that the 221 
exchange between coordinated and free pyridine-d5 in the cis-N,N isomer of compound 6 in solution B 222 
could also be contributing to the broadening of the signals. The strong trans effect produced by the 223 
palladated carbon atom on the coordinated pyridine-d5 in the cis-N,N isomer of compound 6 should 224 
favour this latter exchange [29]. 225 
Interestingly, the 1H NMR of a solution of ca. 6 mg of compound 2 in 1 cm3 of CDCl3 and containing a 226 
molar ratio between pyridined5 and compound 2 of ca. 4 (solution B′) or by reducing the temperature of 227 
solution B to 223 K (solution B00), produced separated signals for the cis- and trans-N,N isomers of 228 
compound 6, as established by 1H NMR at 400 MHz in the first case, and at 500 MHz in the second. 229 
Diagnostic signals for the cis- and the trans-N,N isomers of compound 6 were the broad signals at 7.80 230 
ppm (H10 protons of the cis-N,N isomer) and at 6.12 ppm (H2 proton of the trans-N,N isomer). From 231 
the ratio between the integral of the H2 proton at 6.12 ppm of the trans-N,N isomer of compound 6 and 232 
the integral of the protons of the methoxycarbonyl function of compound 6, which afforded only one 233 
sharp signal for the cis- and trans-isomers of compound 6 at 3.90 ppm in all solutions B, it was 234 
established that in solutions B′ and B00 the ratio between the cisand trans-N,N isomers of compound 6 235 
was ca. 1. 236 
A 1H e 1H COSY recorded on solution B00 at 500 MHz, confirmed the assignment of the proton at 6.12 237 
ppm to the H2 proton of the trans-N,N isomer of compound 6, since this proton in the COSY experiment 238 
showed a sequential correlation with three more aromatic protons, the last identified as the H5 proton of 239 
the orthopalladated phenyl ring of the trans-N,N isomer of compound 6. The H2 proton of the trans-N,N 240 
isomer of compound 6 was shifted at high-field because it was located in the shielding zone of the 241 
coordinated pyridine-d5 [19,25,30,31]. Fig. 3 gives an expansion of the aromatic region of the 1He1H 242 
COSY experiment of solution B00 at 500 MHz showing the COSY signals between the protons of the 243 
ortho-palladated ring of the trans-N,N isomer of compound 6. 244 
NMR data for solutions B, B′ and B00 indicated that a large excess of pyridine-d5 promoted the 245 
geometrical isomerization of compound 6 and, noteworthy, suggested that the cis-N,N isomer of 246 
compound 6 (or 4) was simultaneously the kinetic and thermodynamic control product for the reaction 2 247 
þ 2 py-d5 (or 2py)/6 (or 4) (reaction b). For reaction b, the cis-N,N isomer should be the kinetic control 248 
product of the reaction due to the strong trans effect produced by the metallated carbon atoms into the 249 
chlorido bridge ligands trans to them in the initial compound 2 [29]. 250 
In the 13C{1H} NMR at 101 MHz of solution B and at room temperature, the carbon signals of the 251 
coordinated pyridine-d5, the carbon bonded to the palladium atom, and the carbons of the phenyl 252 
bonded to the iminic nitrogen atom of compound 6 were not observed. On the other hand, the 1H NMR 253 
of solution A at 400 MHz and at room temperature produced narrowsignals for the trans-N,N isomer of 254 
compound 5, and in its 13C{1H} NMR at 101 MHz and at room temperature, all the 13C signals were 255 
observed, except those of the coordinated pyridine-d5. Thus, an exchange between free and coordinated 256 
pyridine-d5 was also taking place in solutions A and B, but this exchangewas taking place at a slower 257 
rate in solution A [19]. The weaker trans effect produced by the iminic nitrogen on the coordinated 258 
pyridine-d5 on the trans-N,N isomer of compound 5, in relation to the trans effect produced by the 259 
palladated carbon atom on the coordinated pyridine-d5 on the cis-N,N isomer of compound 6 should 260 
explain this result [29]. In addition, the bulkier acetato terminal ligand in compound 5 in relation to the 261 
chlorido terminal ligand in compound 6, could also decrease the rate of the exchange in solution A in 262 
relation to solution B. 263 
In order to obtain more information on the relative stability of the cis- and trans-N,N isomers of 264 
compounds 3 and 4, the difference between their electronic energy, absolute enthalpy and absolute 265 
Gibbs free energy in vacuum and in CHCl3 solution were calculated. Table 1 summarizes the results. 266 
Mol files for the optimized geometries for the trans- and cis-isomers of compounds 3 and 4 and the 267 
details of the computational calculations are given in the Supplementary Material. Only the difference of 268 
absolute Gibbs free energy in chloroform solution between the cis- and trans-N,N isomers of compounds 269 
3 and 4 (the last column in Table 1) is discussed because the experimental studies were performed in 270 
CDCl3 solution. It should be noted that although the computational study predicted that for both 271 
compounds the cis-N,N isomerwas the most stable one, experimentally the more stable isomer for 272 
compound 5 was the trans-N,N isomer. However, the computational study predicted in agreement with 273 
what was suggested by the experimental work that i) the thermodynamic preference for the cis-N,N 274 
isomer for compound 4 (with a terminal chlorido ligand) was higher than for compound 3 (with a 275 
terminal acetato ligand), and ii) the difference between the absolute Gibbs free energy in CHCl3 solution 276 
for the cis and trans isomers of compounds 3 and 4 was small. 277 
Relevant to understand the mechanism of the geometrical isomerization of compounds 5 and 6, 278 
compounds 1 and 2 (ca. 6 mg), reacted with pyridine-d5 in D2O (1 cm3) in a molar ratio pyridine-d5/1 279 
or 2 z 50e55 to form solutions C and D, which contained as major compounds, the ionic mononuclear 280 
cyclopalladated complexes 7 (X ¼ OAc) and 8 (X ¼ Cl) of formula [Pd {C6H4CH]N(C6H4-4-281 
CO2Me)-kCortho,kN}(py-d5)2]X (Scheme 1). The ionic complexes 7 and 8 were not isolated but were 282 
characterized in D2O solution by mono- and bidimensional NMR experiments. Ortho-palladated 283 
benzaldehyde and methyl 4-aminobenzoate were also observed by NMR in solutions C and D. The 284 
molar ratio between compounds 7 or 8, ortho-palladated benzaldehyde and methyl 4-aminobenzoate in 285 
solutions C and D was ca. 1.0: 0.2: 0.2. For the ionic complexes 7 and 8, the H2 and H9 protons were 286 
shifted at high-field (6.19 and 7.02 ppm for compound 7 in solution C and at 6.12 and 6.96 ppm for 287 
compound 8 in solution D) because both type of protons were located in the shielding zone of a 288 
pyridine-d5 ligand [19,25,30,31]. 289 
In solutions, C and D, the ortho-palladated benzaldehyde afforded a singlet signal for the proton of the 290 
aldehyde function at ca. 10.5 ppm and an aromatic system corresponding to a 1,2- disubstituted phenyl 291 
ring. On the other hand, methyl 4- aminobenzoate produced signals at ca. 7.7 and 6.7 for the aromatic 292 
protons and at 3.8 ppm for the methoxycarbonyl protons. The exchangeable amino protons of methyl 4-293 
aminobenzoate were not observed in D2O. 294 
The kCortho,kN bidentate chelate coordination mode of the imine ligand in compounds 3 and 4 and 295 
compounds 5e8 in solutions A e D was consistent with the high-field shift of the methinic proton of 296 
these compounds ca. 0.30e0.40 ppm in relation to the free imine ligand [5,6,19,21,22,25] and with the 297 
fact that the metallated and the methinic carbon atoms appeared low-field shifted ca. 10e20 ppm relative 298 
to the free imine ligand [19]. 299 
The detection in solutions C and D of the ionic complexes 7 and 8 suggested that the geometrical 300 
isomerization experimented by compounds 5 and 6 in solutions A and B proceed through the reversible 301 
consecutive displacement mechanism given in Fig. 4. The ionic complex 7 or 8 would not be an 302 
observable intermediate in CDCl3 by 1H NMR but at a high concentration of pyridine-d5 the 303 
thermodynamic equilibrium between the geometrical isomers of compounds 5 and 6 in solutions A and 304 
B would be attained through the intermediate ionic complexes 7 and 8. The reversible character of the 305 
reactions I and II (Fig. 4) was in agreement with the fact that when compound 1 reacted with pyridine in 306 
dichloromethane at room temperature for one day in a molar ratio pyridine/1z50e55, the isolated 307 
compound 3 from this reaction consisted of a mixture of trans- and cis-N,N isomers. 308 
It should be noted that the proposed mechanism for the geometrical isomerization of the discussed 309 
square planar palladium(II) is the most usual mechanism for the geometrical isomerization of square 310 
planar complexes of formula [ML2X2] (M ¼ Pt(II) or Pd(II), L ¼ neutral monodentate ligand, X ¼ 311 
monoanionic monodentate ligand), and it is termed the consecutive displacement mechanism [32]. 312 
In summary, the experimental data indicated that in solutions A and B the trans- and cis-N,N isomers of 313 
compounds 5 and 6 were interconverting between them in a dynamic equilibrium. In addition, an 314 
exchange between free and coordinated pyridine-d5 was also taking place in these solutions. In solution 315 
A, the dynamic equilibrium between the cis- and trans-N,N isomers of compound 5 was shifted to the 316 
trans-N,N isomer. However, NMR data for solution B suggested that in this solution the dynamic 317 
equilibrium between the cis- and trans-N,N isomers of compound 6 was shifted to the cis-N,N isomer. 318 
Interconversion between the trans- and cis- N,N isomers of compounds 5 and 6 in solutions A and B 319 
could proceed through the intermediate ionic complexes of formula [Pd {C6H4CH]N(C6H4-4-CO2Me)-320 
kCortho,kN}(py-d5)2]X, 7 (X ¼ OAc) and 8 (X ¼ Cl). Ionic complexes 7 and 8 were not observed in 321 
CDCl3 solution but were the major species detected by NMR in D2O solutions containing compounds 1 322 
and 2 (ca. 6 mg of 1 or 2 in 1 cm3 of D2O) and pyridine-d5 in a molar ratio pyridine-d5/1 or 2 z 50e55. 323 
A reviewer suggested that a p-stacking interaction between the aryl ring bonded to the iminic nitrogen 324 
and the pyridine could stabilize the cis-N,N isomers of compounds 3 and 4.We have found five crystal 325 
structures of an sp2 N-donor cyclopalladated compound containing an aryl group attached to the sp2 N-326 
donor nitrogen and a pyridine ligand trans to the palladated carbon atom [33e36]. In these crystal 327 
structures, the aryl ring attached to the sp2 N-donor atom and the pyridine are in a face-to-face 328 
conformation. Table 2 gives the distances between the centroids of the aryl ring attached to the sp2 N-329 
donor nitrogen (aromatic ring X) and that of the pyridine (aromatic ring Y) in these crystal structures. 330 
Table 2 shows that only two of these distances are in the range expected for a significant p-stacking 331 
interaction (CCDC numbers 732584 and 848290). 332 
 333 
2.1. Experimental part 334 
1H and 13C{1H} NMR spectra and bidimensional 1He1H and 1He13C NMR experiments were 335 
recorded in a Varian Mercury 400. The 1H NMR at 223 K and the 1He1H COSY experiment at 223 K 336 
were registered at 500 MHz in a Bruker DMX 500 instrument. Chemical shifts were measured relative 337 
to SiMe4 for 1H and to residual solvent peaks for 13C. Chemical shifts are reported in ppm and 338 
coupling constants in Hz. C, H, N microanalyses were performed with a Carlo-Erba EA 1108 339 
instrument. IR spectra were collected with a Nicolet Avatar 300 FT-IR spectrometers using KBr discs. 340 
MALDI-TOF(þ) mass spectra were registered with a VOYAGER-DE-RP spectrometer using dithranol 341 
(DTH), 2,5- dihydroxybenzoic acid (DHB) or trans-2-[3-(4-tert-butylphenyl)- 2-methyl-2-342 
propenylidene]malononitrile (DCTB) as matrix. ESI(þ) mass spectrawere acquired with a LC/MSD-343 
TOF mass spectrometer using H2O/CH3CN (1:1) as eluent. Chemical compounds were commercial and 344 
were used as received. 345 
 346 
 347 
2.1.1. Preparation of C6H5CH]N(C6H4-4-CO2Me) 348 
Methyl (E)-4-(benzylideneamino)benzoate was synthesized by dissolving methyl 4-aminobenzoate 349 
(1465 mg, 9.69 mmol) in methanol (60 cm3) followed by addition of benzaldehyde (1038 mg, 9.78 350 
mmol). The resultant mixture was maintained under reflux for two hours, after which time the crude was 351 
allowed to cool down to room temperature. The solution was concentrated in vacuum (to about 20 cm3) 352 
until precipitation was observed. The pale yellow solid obtained was filtered off and air-dried (1530 mg, 353 
66% yield). 1H NMR (400 MHz, CDCl3, 298 K), d (ppm): 8.44 (s, 1H, 7), 8.08 (d, 3JHH ¼ 8.6 Hz, 2H, 354 
10), 7.92 (dd, 3JHH ¼ 7.7 Hz, 4JHH ¼ 1.8 Hz, 2H, 1), 7.53e7.47 (m, 3H, 2, 3 and 5), 7.21 (d, 3JHH ¼ 355 
8.6 Hz, 2H, 9), 3.93 (s, 3H, 13). 13C-{1H} NMR (101 MHz, CDCl3, 298 K), d (ppm): 166.8 (12), 161.7 356 
(7),156.2 (8),135.7 (6),131.9 (3),130.9 (10),129.1 (1),128.9 (2), 127.4 (11),120.7 (9), 52.0 (13). IR (KBr, 357 
 selected data), y (cm 1): 1717 (C]O st), 1628 (C]N st), 1275 (CeCeO as st), 1114 (CeCeO sym st). MS-358 
ESI (þ) {H2O:CH3CN (1:1)}, m/z: 240.1 (calcd. 240.1) [MþH]þ. Anal. Calcd. for C15H13NO2: C 359 
75.30%, H 5.48%, N 5.85%. Found: C 74.6%, H 5.3%, N 5.9%. 360 
 361 
2.1.2. Preparation of compound 1 362 
A solution formed by palladium(II) acetate (226 mg, 1.01 mmol), methyl (E)-4-363 
(benzylideneamino)benzoate (241 mg, 1.01 mmol) and 10 cm3 of glacial acetic acid was heated to 60 364 
  C for 24 h. Afterwards, the solvent of the orange suspension formed was removed under vacuum and 365 
the residue subjected to column chromatography (silica gel-60) using a 100: 4 chloroform: methanol 366 
mixture as eluent. The red coloured band was collected and evaporated. Addition of the minimum 367 
amount of diethyl ether (ca. 4 cm3) gave the target complex as a yellow orangey solid (195 mg, 48% 368 
yield). 1H NMR (400 MHz, CDCl3, 298 K), d (ppm): 7.86 (d, 3JHH ¼ 8.6 Hz, 2H, 10), 7.72 (s, 1H, 7), 369 
7.28 (dd, 3JHH ¼ 7.5 Hz, 4JHH ¼ 1.4 Hz, 1H, 5), 7.11 (td, 3JHH ¼ 7.4 Hz, 4JHH ¼ 1.0 Hz, 1H, 4), 370 
6.94 (td, 3JHH ¼ 7.6 Hz, 4JHH ¼ 1.5 Hz, 1H, 3), 6.86 (d, 3JHH ¼ 8.6 Hz, 2H, 9), 6.58 (dd, 3JHH ¼ 7.8 371 
Hz, 4JHH ¼ 0.8 Hz, 1H, 2), 3.95 (s, 3H, 13), 1.86 (s, 3H, 15). 13C{1H} NMR (101 MHz, CDCl3, 298 372 
K), d (ppm): 180.6 (14), 173.5 (7), 166.4 (12), 155.7 (1), 150.9 (8), 145.3 (6), 132.5 (2), 131.2 (3), 131.1 373 
(10), 129.6 (11), 128.9 (5), 128.2 (4), 124.2 (9), 52.3 (13), 24.2 (15). IR (KBr, selected  data), y (cm 1): 374 
1717 (C]O st, ester), 1609 (C]N st), 1574 (COO as st, bridging carboxylato), 1415 (COO sym st, 375 
bridging carboxylato), 1282 (CeCeO as st), 1114 (CeCeO sym st). MS-LDI TOF (þ) (CHCl3), m/z: 376 
746.9 (calcd. 747.0)  [M  OAc]þ. Anal. Calcd. for C34H30N2O8Pd2: C 50.57%, H 3.74%, N 3.47%. 377 
Found: C 50.4%, H 3.8%, N 3.5%. 378 
 379 
2.1.3. Preparation of compound 2 380 
A mixture formed by acetato-bridge complex 1 (200 mg, 0.25 mmol), lithium chloride (42 mg, 1 mmol) 381 
and acetone (10 cm3) was stirred at room temperature for 2 h. Afterwards, the solvent of the orange 382 
mixture formed was eliminated under vacuum, and the residue eluted through a silica gel-60 column 383 
chromatography using dichloromethane:methanol (100:2) as eluent. The yellowish band was collected 384 
and concentrated in vacuum. Addition of diethylether (5 cm3) to the residue produced the precipitation 385 
of compound 2 as a yellow solid, which was filtered and dried in vacuum (99 mg, 53% yield). 1H NMR 386 
(400 MHz, CDCl3, 298 K), d (ppm): 8.11 (br d, 3JHH ¼ 7.6 Hz, 2H, 10), 8.01 (s, 1H, 7), 7.44 (br d, 387 
3JHH ¼ 7.3 Hz, 2H, 9), 7.35e7.33 (m, 2H, metallated ring), 7.10 (br s, 2H, metallated ring), 3.96 (s, 3H, 388 
13). Solubility in chloroform was insufficient to obtain carbon NMR data. IR (KBr, selected data), y 389 
 (cm 1): 1719 (C]O st), 1605 (C]N st), 1284 (CeCeO as st), 1116 (CeCeO sym st). MS-LDI TOF (þ) 390 
(acetone), m/z: 722.8 (calcd.  722.9) [M  Cl]þ. Anal. Calcd. for C30H24Cl2N2O4Pd2: C 47.39%, H 391 
3.18%, N 3.68%. Found: C 47.6%, H 3.3%, N 3.6%. 392 
 393 
2.1.4. Preparation of compound 3 394 
100 mg of complex 1 (0.124 mmol) were treated with 6 cm3 of a solution of pyridine in CH2Cl2 0.064 395 
M (0.384 mmol of pyridine). The solution was allowed to stir at room temperature for 2 h, and thereafter 396 
volatiles were evaporated under reduced pressure. Upon addition of diethyl ether (4 cm3) a light yellow 397 
precipitate formed, which was collected by filtration and air-dried (98 mg, 82% yield). Compound 3 398 
consists of a mixture of trans-N,N and cis-N,N isomers in a 1.0 : 0.8 ratio. A similar result was obtained 399 
reacting 100 mg (0.124 mmol) of compound 1 with 399 mg (ca. 5 mmol) of pyridine in10 cm3 of 400 
CH2Cl2 stirring at room temperature for 24 h. In this case, the 1H NMR in CDCl3 solution of the 401 
isolated compound 3 showed that it consisted of a mixture of trans- and cis-N,N isomers in 1 : 0.56 402 
ratio. 1H NMR (400 MHz, CDCl3, 298 K), d (ppm): [trans- N,N] 9.04 (d, 3JHH ¼ 8.0 Hz, 2H, o-py), 403 
8.09 (s, 1H, 7), 8.08 (d, 3JHH ¼ 8.6 Hz, 2H,10), 7.88 (tt, 3JHH ¼ 7.6 Hz, 4JHH ¼ 1.6 Hz, 1H, p-py), 404 
7.49 (d, 3JHH ¼ 8.6 Hz, 2H, 9), 7.47e7.44 (m, 2H, m-py), 7.42 (dd, 3JHH ¼ 7.4 Hz, 4JHH ¼ 1.5 Hz, 405 
1H, 5), 7.12e7.07 (m, overlapped with 4 of cis-N,N, 1H, 4), 7.01 (td, 3JHH ¼ 7.5 Hz, 4JHH ¼ 1.5 Hz, 406 
1H, 3), 6.29 (d, 3JHH ¼ 7.6 Hz, 1H, 2), 3.93 (s, 3H, 13), 1.55 (s, 3H, 15); [cis-N,N] 8.60 (br d, 2H, o-407 
py), 7.86 (d, 3JHH ¼ 8.6 Hz, partially overlapped with ppy of trans-N,N, 2H, 10), 7.72 (s, 1H, 7), 7.67 408 
(tt, 3JHH ¼ 7.8 Hz, 4JHH ¼ 1.7 Hz, 1H, p-py), 7.29e7.26 (m, partially overlapped with CHCl3, 3H, 5 þ 409 
m-py), 7.12e7.07 (m, overlapped with 4 of trans-N,N, 1H, 4), 6.94 (td, 3JHH ¼ 7.6 Hz, 4JHH ¼ 1.5 Hz, 410 
1H, 3), 6.86 (d, 3JHH ¼ 8.6 Hz, 2H, 9), 6.58 (dd, 3JHH ¼ 7.8 Hz, 3JHH ¼ 0.7 Hz, 1H, 2), 3.95 (s, 3H, 411 
13), 1.86 (s, 3H, 15). 13C{1H} NMR (101 MHz, CDCl3, 298 K), d (ppm): [trans-N,N] 177.6 (14), 412 
175.9 (7), 166.4 (12), 157.4 (1), 153.4 (o-py), 151.9 (8),146.7 (6),138.1 (p-py), 133.0 (2), 131.5 (3), 413 
130.2 (10), 129.2 (11), 129.1 (5), 125.4 (m-py), 124.6 (4), 123.1 (9), 52.2 (13), 24.5 (15); [cis-N,N] 414 
180.6 (14), 173.5 (7), 166.4 (12), 155.7 (1),150.9 (8),149.9 (br s, o-py),145.3 (6),136.0 (br s, p-py),132.5 415 
(2), 131.1 (3), 129.6 (10), 128.9 (11), 128.1 (5), 124.2 (4), 123.8 (br s, mpy), 123.2 (9), 52.3 (13), 24.2 416 
 (15). IR (KBr, selected data), y (cm 1): 1720 (C]O st, ester), 1604 (C]N st), 1586 (C]O st, terminal 417 
acetato), 1378 (CeO st, terminal acetato), 1271 (CeCeO as st), 1108 (CeCeO sym st). MS-MALDI TOF 418 
(þ) (DHB), m/z: 422.9 (calcd.  423.0) [M  OAc]þ. Anal. Calcd. for C22H20N2O4Pd: C 54.73%, H 419 
4.18%, N 5.80%. Found: C 54.7%, H 4.3%, N 6.1%. 420 
 421 
2.1.5. Preparation of compound 4 422 
0.100 g (0.132 mmol) of compound 2 were treated with 6 cm3 of a solution pyridine in CH2Cl2 423 
0.064M(0.384 mmol of pyridine). The solution was allowed to stir at room temperature for 2 h, and 424 
thereafter volatiles were evaporated under reduced pressure. Upon addition of diethyl ether (4 cm3) a 425 
light yellow precipitate formed, which was collected by filtration and air-dried (107 mg, 97% yield). 426 
Compound 4 consists of a mixture of trans-N,N and cis-N,N isomers in a 1.0 : 0.5 ratio. A similar result 427 
was obtained reacting 100 mg (0.132 mmol) of compound 2 with 417 mg (ca. 5.3 mmol) of pyridine in 428 
10 cm3 of CH2Cl2 stirring at room temperature for 24 h. In this case, the 1H NMR in CDCl3 solution of 429 
the isolated compound 2 showed that it consisted of a mixture of trans- and cis-N,N isomers in 1.0 : 0.6 430 
ratio. 1H NMR (400 MHz, CDCl3, 298 K), d (ppm): [trans- N,N] 8.93 (d, 3JHH ¼ 5.0 Hz, 2H, o-py), 431 
8.12 (s, 1H, 7), 8.09 (d, 3JHH ¼ 9.2 Hz, 2H, 10), 7.88 (t, 3JHH ¼ 7.5 Hz, 1H, p-py), 7.51 (d, 3JHH ¼ 432 
8.4 Hz, 2H, 9), 7.60e7.41 (m, overlapped with 5 of cis-N,N, 3H, m-py þ 5), 7.15e7.11 (m, overlapped 433 
with m-py, 9 and 4 of cis- N,N, 1H, 4), 7.05 (t, 3JHH ¼ 7.6 Hz, 1H, 3), 6.20 (d, 3JHH ¼ 7.6 Hz, 1H, 2), 434 
3.92 (s, 3H,13); [cis-N,N] 8.36 (br d, 2H, o-py), 8.16 (s, 1H, 7), 7.76 (br d, 10), 7.60 (br t, 3JHH ¼ 7.4 435 
Hz, 1H, p-py), 7.52e7.41 (m, overlapped with m-py,10 and 5 of trans-N,N, 1H, 5), 7.24 (t, 3JHH ¼ 7.6 436 
Hz, 1H, 3), 7.15e7.11 (m, overlapped with 4 of trans-N,N, 3H, m-py þ 4 and 2), 7.00 (d, 3JHH ¼ 8.0 437 
Hz, 2H, 9), 3.89 (s, 3H, 13). 13C{1H} NMR (101 MHz, CDCl3, 298 K), d (ppm): [trans-N,N] 176.9 (7), 438 
166.4 (12), 158.7 (1), 153.2 (o-py), 152.5 (8), 146.4 (overlapped with 6 of cis- N,N, 6), 138.2 (p-py), 439 
132.2 (2), 131.8 (3), 130.0 (10), 129.3 (11), 129.1 (overlapped with 5 of cis-N,N, 5), 125.6 (m-py), 440 
124.9 (overlapped with m-py of cis-N,N, 4), 123.8 (9), 52.1 (13); [cis-N,N] 176.8 (7), 165.9 (12), 157.0 441 
(1), 152.2 (8), 150.6 (o-py), 146.4 (overlapped with 6 of trans-N,N, 6), 137.5 (br s, p-py), 136.7 (2), 442 
131.7 (3), 130.4 (10), 129.1 (overlapped with 5 of trans-N,N, 5), 128.9 (11), 124.9 (overlapped with 4 of 443 
trans-N,N, m-py), 124.6 (4), 122.5 (9), 52.3 (13). IR  (KBr, selected data), y (cm 1): 1715 (C]O st), 444 
1604 (C]N st), 1587 (C]N st pyridine), 1277 (CeCeO as st), 1113 (CeCeO sym st). MSESI (þ) 445 
 {H2O:CH3OH (1:1)}, m/z: 881.0 (calcd. 881.0) [2 M Cl]þ, 802.0 (calcd.  802.0) [2 M Cl e py]þ, 446 
423.0 (calcd.  423.0) [M Cl]þ. Anal. Calcd. for C20H17ClN2O2Pd: C 52.31%, H 3.73%, N 6.10%. 447 
Found: C 51.9%, H 3.8%, N 6.3%. 448 
 449 
2.1.6. Preparation of solution A 450 
Solution Awas prepared by adding ca. 30mg (30 mL) of pyridined5 to a suspension of compound 1 (ca. 451 
6 mg) in 1 cm3 of CDCl3 (molar ratio pyridine-d5/compound 1 z 50e55). 1H NMR (400 MHz, CDCl3 þ 452 
py-d5, 298 K), d (ppm) (compound 5): 8.12 (s, 1H, 7), 8.08 (d, 3JHH ¼ 8.6 Hz, 2H, 10), 7.50 (d, 3JHH 453 
¼ 8.6 Hz, 2H, 9), 7.42 (dd, 3JHH ¼ 7.4 Hz, 4JHH ¼ 1.3 Hz, 1H, 5), 7.09 (td, 3JHH ¼ 7.4 Hz, 4JHH ¼ 454 
0.9 Hz, 1H, 4), 7.01 (td, 3JHH ¼ 7.6 Hz, 3JHH ¼ 1.5 Hz, 1H, 3), 6.29 (d, 3JHH ¼ 7.5 Hz, 1H, 2), 3.93 455 
(s, 3H, 13), 1.56 (s, 3H, 15). 13C{1H} NMR (101 MHz, CDCl3 þ py-d5, 298 K), d (ppm) (compound 456 
5): 177.6 (s, 14), 175.9 (s, 7), 166.4 (s, 12), 157.3 (s, 1), 151.9 (s, 8), 146.7 (s, 6), 133.0 (s, 2),131.5 (s, 457 
3),130.2 (s,10),129.2 (s,11),129.1 (s, 5),124.5 (s, 4), 123.1 (s, 9), 52.2 (s, 13), 24.5 (s, 15). Due to the 458 
rapid exchange between coordinated and free pyridine-d5, carbon NMR signals of coordinated pyridine-459 
d5 were not observed. 460 
 461 
2.1.7. Preparation of solution B 462 
Solution Bwas prepared by adding ca. 30mg (30 mL) of pyridined5 to a suspension of compound 2 (ca. 463 
6 mg) in 1 cm3 of CDCl3 (molar ratio pyridine-d5/compound 2 z 50e55). 1H NMR (400 MHz, CDCl3 þ 464 
py-d5, 298 K), d (ppm) (compound 6): 8.12 (s, 1H, 7), 7.98 (br d, 2H,10), 7.43 (m, 1H, 5), 7.31 (br 465 
signal, 2H), 7.11 (br d, 2H, 9) 3.89 (s, 3H, 13). 13C{1H} NMR (101 MHz, CDCl3 þ py-d5, 298 K), d 466 
(ppm) (compound 6): 176.8 (s, 7), 166.2 (s, 12), 146.4 (s, 6), 131.8 (s, 3), 130.1 (br s, 2), 129.1 (s, 5), 467 
124.9 (s, 4), 52.2 (s, 13). Due to the rapid exchange between coordinated and free pyridine-d5, carbon 468 
NMR signals of coordinated pyridine-d5 and some carbon peaks of the cyclopalladated ligand could not 469 
be observed (C1 and C8 e C11). 470 
 471 
2.1.8. Preparation of solution C 472 
Solution Cwas prepared by adding ca. 30mg (30 mL) of pyridined5 to a suspension of acetato-bridge 473 
cyclopalladated compound 1 (6 mg, approx.) in deuterated water (ca. 1 cm3) (molar ratio pyridine- 474 
d5/compound 1 z 50e55). 1H NMR in D2O revealed the presence of the cationic complex 7, together 475 
with ortho-palladated benzaldehyde and methyl 4-aminobenzoate in a 1.0 : 0.2 : 0.2 ratio. 1H NMR (400 476 
MHz, D2O þ py-d5, 298 K), d (ppm); compound 7: 8.22 (s, 1H, 7), 7.69 (d, 3JHH ¼ 8.8 Hz, 2H, 10), 477 
7.58 (dd, 3JHH ¼ 7.5 Hz, 4JHH ¼ 1.2 Hz, 1H, 5), 7.24 (td, 3JHH ¼ 7.5 Hz, 4JHH ¼ 1.0 Hz, 1H, 4), 478 
7.11 (td, 3JHH ¼ 7.6 Hz, 4JHH ¼ 1.5 Hz, 1H, 3), 7.02 (d, 3JHH ¼ 8.8 Hz, 2H, 9), 6.19 (dd, 3JHH ¼ 7.6 479 
Hz, 4JHH ¼ 0.8 Hz, 1H, 2), 3.83 (s, 3H, 13), 1.90 (s, 3H, 15); ortho-palladated benzaldehyde: 10.50 (s, 480 
1H, CH]O), 8.02 (d, 3JHH ¼ 7.5 Hz, 1H), 7.53 (dd, 3JHH ¼ 7.6 Hz, 4JHH ¼ 1.3 Hz, 1H), 7.30 (td, 481 
3JHH ¼ 7.7 Hz, 4JHH ¼ 1.6 Hz, 1H), 7.13e7.06 (4JHH ¼ 1.1 Hz, partially obscured by 3 of 7, 1H), 482 
1.90 (s, 3H, 15); methyl 4- aminobenzoate: 7.73 (d, 3JHH ¼ 8.9 Hz, 2H), 6.74 (d, 3JHH ¼ 8.9 Hz, 2H), 483 
3.79 (s, 3H). Signal of exchangeable amino protons was not observed in D2O. 484 
 485 
2.1.9. Preparation of solution D 486 
Solution D was prepared by adding ca. 30 mg (30 mL) of pyridine- d5 to a suspension of chlorido-487 
bridge cyclopalladated compound 2 (ca. 6 mg) in deuterated water (ca. 1 cm3) (molar ratio pyridine-488 
d5/compound 2 z 50e55). 1H NMR in D2O revealed the presence of the cationic complex 8, together 489 
with ortho-palladated benzaldehyde and methyl 4-aminobenzoate in a 1.0 : 0.2 : 0.2 ratio. 1H NMR (400 490 
MHz, D2O þ py-d5, 298 K), d (ppm); compound 8: 8.16 (s, 1H, 7), 7.64 (d, 3JHH ¼ 8.4 Hz, slightly 491 
overlapped with 2H of methyl 4-aminobenzoate, 2H, 10), 7.56 (d, 3JHH ¼ 7.5 Hz, 1H, 5), 7.22 (t, 3JHH 492 
¼ 7.5 Hz, 1H, 4), 7.09e7.04 (m, overlapped with 1H of metallated aldehyde, 1H, 3), 6.96 (d, 3JHH ¼ 493 
8.4 Hz, 2H, 9), 6.12 (d, 3JHH ¼ 7.8 Hz, 1H, 2), 3.80 (s, 3H, 13); ortho-palladated benzaldehyde: 10.45 494 
(s, 1H, CH]O), 7.98 (d, 3JHH ¼ 7.2 Hz, 1H), 7.47 (d, 3JHH ¼ 7.6 Hz, 1H), 7.27 (t, 3JHH ¼ 7.6 Hz, 495 
1H), 7.09e7.04 (m, overlapped with 3 of 8, 1H); methyl 4-aminobenzoate: 7.68 (d, 3JHH ¼ 8.5 Hz, 496 
slightly overlapped with 10 of 8, 2H), 6.72 (d, 3JHH ¼ 8.5 Hz, 2H, 9), 3.76 (s, 3H, 13). Signal of 497 
exchangeable amino protons was not observed in D2O. 498 
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Legends to figures 562 
 563 
Scheme 1.  i) Pd(OAc)2, HOAc, 60 C, molecular ratio methyl (E)-4-564 
(benzylideneamino)benzoate/Pd(OAc)2 ¼ 1; ii) LiCl excess, acetone, room temperature; iii) pyridine, 565 
CH2Cl2, room temperature, molar ratio pyridine/1 or 2z 3; iv) pyridine-d5, CDCl3, room temperature, 566 
molar ratio pyridine-d5/1 or 2 z50e55, v) pyridine-d5, D2O, room temperature, molar ratio pyridine-567 
d5/1 or 2 z 50e55. Reactions in deuterated solvent were performed treating ca. 6 mg of compound 1 or 2 568 
with 1 cm3 of the corresponding deuterated solvent and ca. 30 mg (30 mL) of pyridine-d5. 569 
 570 
Fig. 1 XRD molecular structure of compound 1. Hydrogen atoms and solvent molecules have been 571 
 omitted for clarity. Selected bond distances (Å) and angles ( ): Pd(1) eC(5) 1.993(6), Pd(1)eO(3) 572 
2.041(4), Pd(1)eN(1) 2.052(4), Pd(1)eO(1) 2.161(4), Pd(1) ePd(2) 2.9175(13), Pd(2)eC(20) 1.982(5), 573 
Pd(2)eO(2) 2.050(4), Pd(2)eN(2) 2.054(5), Pd(2)eO(4) 2.156(4), N(1)eC(11) 1.298(7), N(2)eC(26) 574 
1.299(7), C(25)eC(26) 1.444(7), C(10)eC(11) 1.425(7), C(20)eC(25) 1.364(7), C(5)eC(10) 1.411(8), 575 
C(5)ePd(1)eO(3) 92.4(2), C(5)ePd(1)eN(1) 81.0(2), O(3)ePd(1)eN(1) 173.13(17), C(5)ePd(1)eO(1) 576 
175.28(18), O(3)ePd(1)eO(1) 88.60(17), N(1)ePd(1)eO(1) 97.84(17), C(20)ePd(2) eO(2) 91.8(2), 577 
C(20)ePd(2)eN(2) 80.7(2), O(2)ePd(2)eN(2) 172.53(17), C(20)ePd(2) eO(4) 175.24(18), 578 
O(2)ePd(2)eO(4) 88.15(16), N(2)ePd(2)eO(4) 99.25(17), C(10)eC(5) ePd(1) 112.4(4), 579 
C(5)eC(10)eC(11) 115.4(5), N(1)eC(11)eC(10) 117.2(5), C(11)eN(1) ePd(1) 113.9(4), 580 
C(26)eN(2)ePd(2) 112.7(4), N(2)eC(26)eC(25) 117.6(5), C(20)eC(25) eC(26) 114.5(5), 581 
C(25)eC(20)ePd(2) 114.3(4). 582 
 583 
Fig. 2 XRD molecular structure of compound 2. Hydrogen atoms have been omitted for clarity. Selected 584 
bond distances and angles: Pd1eC3 1.980 (13), Pd1eN10 2.089 (9), Pd1eCl2 2.337 (3), Pd1eCl2i 2.464 585 
(3), C9eN10 1.304 (15), C8eC9 1.414 (17), C3eC8 1.428 (16), C3ePd1eN10 81.6 (4), C3ePd1eCl2 93.7 586 
(3), N10ePd1eCl2 174.6 (3), C3ePd1eCl2i 177.1 (4), N10ePd1eCl2i 100.5 (3), Cl2ePd1eCl2i 84.08 587 
(10), Pd1e- Cl2ePd1i 95.92 (10), C11eN10ePd1 127.9 (7), N10eC9eC8 119.6 (10), C9eC8eC3 114.6 588 
(11), C8eC3ePd1 112.4 (9). 589 
 590 
Fig. 3 Expansion of the aromatic region of the 1He1H COSY experiment at 500 MHz of solution B00 591 
(solution B at 223 K). * Residual CHCl3 in CDCl3. ** Residual p-C5HD4N in pyridined5. *** Residual 592 
m-C5HD4N in pyridine-d5. 593 
 594 
Fig. 4 Consecutive reversible reactions between the species present in solutions A and B, which could 595 
explain the geometrical isomerization taking place in these solutions. 596 
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 600 
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FIGURE 1 603 
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FIGURE 2 608 
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FIGURE 3 614 
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FIGURE 4 618 
 619 
 620 
621 
Table 1 Energy differences calculated at the DFT/B3LYP level between the cis- and trans-N,N isomers 622 
 for compounds 3 and 4 in kcal mol 1. Positive values indicate that the trans-N,N isomer is more stable 623 
than the cis-N,N isomer. DE ¼ electronic energy(cis-  N,N)  electronic energy(trans-N,N). DH ¼ 624 
absolute enthalpy(cis-  N,N)  absolute enthalpy(trans-N,N). DG ¼ absolute Gibbs free energy(cis-N,N) 625 
   absolute Gibbs free energy(trans-N,N). v ¼ vacuum. CHCl3 ¼ chloroform solution. 626 
 627 
 628 
 629 
 630 
631 
Table 2 Distances in Å between the centroids of the aromatic rings X and Y (see the text for the 632 
definition of the aromatic rings X and Y). 633 
 634 
 635 
